Key result
Rheumatoid disease is associated with an increased risk of cardiovascular mortality, ischaemic heart disease, and heart failure, potentially independent of traditional risk factors.
Rheumatoid disease is associated with increased cardiovascular mortality and morbidity, necessitating further evaluation of rheumatoid heart disease prevalence in the context of modern disease-modifying therapies.
Answers are grounded in this paper and cite their sources.
Warrants CV risk consideration in rheumatoid patients; leaves open impact of modern disease-modifying therapies.
Rheumatoid disease (RD) is a common chronic inflammatory condition associated with progressive joint destruction. Sufferers of RD experience reduced life expectancy, reflected in the increased standardised mortality rates reported in several studies over the last 50 years. Most studies indicate that the increased mortality affecting this population is mainly due to cardio-vascular disease. Epidemiological data have revealed an increased risk of developing ischaemic heart disease and heart failure in RD. The increased risk of ischaemic heart disease may result from traditional risk factors but data suggest that RD may confer risk independently. Although pericardial involvement, valvopathy and myocarditis are the most well-recognised cardiac manifestations of RD, and constitute a rheumatoid heart disease, these features are relatively benign. The current prevalence of rheumatoid heart disease in the era of early administration of disease-modifying therapy requires evaluation.
No takes yet. Share an insight, caveat, or question.
Bhatia et al. (2005) conducted a review in Rheumatoid disease. Rheumatoid disease was evaluated. Rheumatoid disease is associated with an increased risk of cardiovascular mortality, ischaemic heart disease, and heart failure, potentially independent of traditional risk factors.
Synapse has enriched 10 related papers. Consider them for comparative context: